SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Valentis (VLTS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (16)7/15/1999 12:12:00 PM
From: Mike McFarland   of 81
 
that the date at which Eli Lilly & Company may
extend or terminate its collaborative research agreement
with the Company has been deferred from May 1999 to
November 30, 1999
biz.yahoo.com

''Valentis is pleased to continue to work with Lilly,'' stated Benjamin F. McGraw, III, Chairman, CEO and President of Valentis. ''We are encouraged by the results that we have seen to date incorporating BRCA-1 into our delivery and expression systems.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News